Camber Capital Management’s Evolent Health EVH Stock Holding History

Camber Capital Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$9.57M	Sell	850,000 -2,150,000	-72%	-$19.7M	0.9%	19
2025 Q1	$28.4M	Sell	3,000,000 -1,000,000	-25%	-$10.1M	1.01%	20
2024 Q4	$45M	Buy	4,000,000 +2,600,000	+186%	+$45.7M	1.04%	21
2024 Q3	$39.6M	Buy	1,400,000 +775,000	+124%	+$20M	1.26%	22
2024 Q2	$11.9M	Buy	+625,000	New	+$16M	0.33%	33
2022 Q3	–	Sell	-1,000,000	Closed	-$30.7M	–	46
2022 Q2	$30.7M	Buy	1,000,000 +814,600	+439%	+$23.7M	1.33%	22
2022 Q1	$5.99M	Buy	+185,400	New	+$4.85M	0.22%	35

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Camber Capital Management's EVH Position: Q2 2025 in Review

Camber Capital Management reduced its Evolent Health (EVH) stake by 72% in Q2 2025, selling an estimated $19.7M and leaving 850,000 shares worth $9.57M. The position accounts for 0.9% of the portfolio, ranked #19.

Camber Capital Management first reported a position in EVH in Q1 2022 and has held it in 7 quarters since. The position peaked at $45M in Q4 2024. 220 funds tracked by Wall St. Rank hold EVH as of Q2 2025.

Camber Capital Management held 850,000 shares of Evolent Health worth $9.57M as of Q2 2025.
Camber Capital Management sold 2,150,000 Evolent Health shares in Q2 2025, an estimated $19.7M.
Evolent Health made up 0.9% of Camber Capital Management's portfolio in Q2 2025, its #19 holding.
Camber Capital Management first reported a position in Evolent Health in Q1 2022 and has held it in 7 quarters since.
Camber Capital Management's Evolent Health position peaked at $45M in Q4 2024.
220 funds tracked by Wall St. Rank held Evolent Health as of Q2 2025.

Based on Camber Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.